Hengrui (Group)

https://www.hengrui.com

	Start	2020-04-19 existent
	Predecessor	Jiangsu Hengrui Medicine Co., Ltd.
	Industry	pharmaceutical

	City	n. a. Jiangsu province
		Address record changed: 2023-10-30

Basic data	Employees	n. a.


		Record changed: 2024-09-22

Picture EBD Group Biotech Showcase 2025 San Francisco BTS25 650x200px

More documents for Hengrui (Group)

[1] Merck KGaA. (10/30/23). "Press Release: Merck Strengthens Oncology Pipeline Through Strategic Partnership with Hengrui for Next-Generation Selective PARP1 Inhibitor and Antibody-Drug Conjugate [Not intended for US-, Canada- or UK-based media]". Darmstadt...
[2] Aiolos Bio, Inc.. (10/24/23). "Press Release: Aiolos Bio Launches with $245 Million Series A Investment to Advance Development of Novel, Phase 2-Ready TSLP Antibody". San Francisco, CA & London....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]